Autopsy report · NCT03887442

Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy

“low recruitment rate”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 8 months before it stopped.
• 17 participants enrolled.
• Results were posted on the registry 8 years 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Sponsor type

University, hospital or other

Conditions

Head and Neck Cancer

Interventions

Paclitaxel; Cetuximab + Paclitaxel

Participants

17

Trials that died the same way

• NHFOV Versus NCPAP to Prevent Exubation Failure
  “Poor recruitment rate” (95% match in meaning)
• Whole-body Vibration Physiotherapy in Kidney Transplantation
  “Due to low recruitment rate” (90% match in meaning)
• Study to Evaluate the Learning Curve to Anchor GYN-CS® Device
  “slow recruitment rate” (89% match in meaning)
• Intraarticular Corticosteroid Therapy in Perthes Disease.
  “low recruitment” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.